|
|
Acute
Illness
Protocols |
|
Metabolic
Consultation |
 |
Feedback |
|
Discussion
Forum |
 |
Poll |
--Please
review the contents of these protocols and submit your comments to be
considered for the final online publication--
INTRODUCTION
3-HMG
CoA Lyase deficiency is one of several defects in the degradation pathway
of leucine (a major branched-chain amino acid). Most of the defects
produce metabolic ketoacidosis but ketones are absent or low despite
acidosis and hypoglycemia in 3-HMG CoA Lyase deficiency. Thus, this
is a cause of hypoketotic hypoglycemia. The pathway is as follows:
PATHOPHYSIOLOGY
In
the presence of catabolism or substantially reduced food intake (e.g.
infection, severe exertion), the combination of an increased cellular
requirement for energy and reduced glucose intake results in proteolysis
with release of amino acids and fatty acids. Enhanced leucine and fatty
acid degradation is an attempt by the body to produce the needed energy
in the form of ketones. When 3-HMG-CoA lyase is deficient, the increased
fluxes in both leucine degradation and fatty acid oxidation result in
an accumulation of 3-hydroxymethylglutaryl-CoA. The accumulated substrate
produces metabolic acidosis, inhibits gluconeogenesis resulting
in hypoglycemia, and inhibits the urea cycle resulting in hyperammonemia.
PRESENTATION
- Vomiting
- Lethargy
- Encephalopathy
- Hypotonia
- Failure to thrive
- Hepatomegaly
- Reye syndrome
picture
- Developmental
delay
- Seizures
- Sudden death
Parents of children
with metabolic disorders know the early signs of decompensation in THEIR
children. Listen to them !!!
DIAGNOSIS
ASSESSMENT
Assess for dehydration, fever, infection or other stessors that
may precipitate an acute metabolic episode. Clinical decompensation
can occur rapidly in an infant and may be more gradual in older children.
INVESTIGATIONS
- Blood glucose
(? hypoglycemia)
- pH, blood gases,
(? metabolic acidosis)
- electrolytes
(? low biocarbonate)
- ammonia (? hyperammonemia)
- urine ketones
(? absent or trace)
- urinalysis
- AST, ALT, AP,
PT, PTT
- urine organic
acids
- culture of blood,
throat, urine as indicated
ASSESS BIOCHEMICAL
PARAMETERS REGULARLY AND FREQUENTLY WHILE SICK
THERAPY
TREATMENT
1. INDICATION
FOR IV (NEVER less than 10% dextrose infusion)
(One or more indication is sufficient for IV)
- Vomiting
- Hypoglycemia
- Poor PO intake
- Dehydration Do
not rely on ketones as indicating dehydration!
- Decreased alertness
- Metabolic acidosis
Start 10% glucose
continuous infusion at 1.5x maintenance to provide 7-8mg/kg/min
2. DO NOT ADMINISTER LIPIDS IN ANY FORM
3. HYPOGLYCEMIA
Push 25% dextrose 2ml/kg and follow with a continuous 10%
dextrose infusion at 1.5x maintenance to provide 7-8mg/kg/min glucose
4. METABOLIC ACIDOSIS (Bicarbonate level<16)
Must be treated aggressively with IV Sodium bicarbonate
(1 mEq/kg). Treating conservatively in the expectation of a re-equilibration
of acid/base balance as other biochemical/clinical parameters are normalized
can lead to tragic consequences.
5. CARNITINE
Should be provided PO (100-200 mg/kg/day divided TID) or
IV (30-50 mg/kg/day).
6. PRECIPITATING FACTORS
Should be treated aggressively to help minimize further
catabolism
7. APPARENTLY WELL
If drinking oral fluids well and none of the above
factors present, there is no need for emergent IVI. But history of earlier
vomiting, pyrexia, or other stressor should be taken seriously and a
period of observation undertaken to ensure that PO fluids are taken
frequently and well tolerated, with glucose status monitered periodically.
In conjunction with this protocol, please call or have paged the
genetics metabolism fellow on call, or failing this, the metabolic attending
on call at your hospital or nearest pediatric tertiary care center.
Last
Updated: Wednesday, September 6, 2006
|